×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BCAX – bicara therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BCAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
07:30 am
bcax
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/11
04:01 pm
bcax
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference
Medium
Report
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference
11/6
06:32 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
11/5
07:30 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock.
Low
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock.
10/8
08:39 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
10/8
07:32 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $47.00 price target on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $47.00 price target on the stock.
10/8
07:32 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
10/8
07:32 am
bcax
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $35.00 price target on the stock.
Medium
Report
Bicara Therapeutics Inc. (NASDAQ: BCAX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $35.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: